These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process. Park J, Cho W, Cha KH, Ahn J, Han K, Hwang SJ. Int J Pharm; 2013 Jan 30; 441(1-2):50-5. PubMed ID: 23262425 [Abstract] [Full Text] [Related]
6. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD, Ju TC, Lee PI. Eur J Pharm Biopharm; 2012 May 30; 81(1):149-58. PubMed ID: 22233548 [Abstract] [Full Text] [Related]
8. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Tian Y, Jones DS, Andrews GP. Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314 [Abstract] [Full Text] [Related]
9. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S, O'Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO. AAPS PharmSciTech; 2016 Feb 06; 17(1):106-19. PubMed ID: 26335416 [Abstract] [Full Text] [Related]
11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V, Tajber L, Corrigan OI, Healy AM. Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367 [Abstract] [Full Text] [Related]
18. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy. Song Y, Yang X, Chen X, Nie H, Byrn S, Lubach JW. Mol Pharm; 2015 Mar 02; 12(3):857-66. PubMed ID: 25585133 [Abstract] [Full Text] [Related]